DAY ONE BIOPHARMACEUTICALS
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98975225
- Registration number
- 8189842
- Mark type
- Design + words
- Filed
- 21 Sept 2023
- Published for opposition
- 20 May 2025
- Registered
- 24 Mar 2026
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for treating cancer and oncological diseases; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological, neurological, and immune system related diseases and disorders; medical preparations for the delivery of compounds to the body for the treatment and prevention of oncological, neurological, and immune system related diseases and disorders
- Class 036 — Insurance and financial services: Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, assessing sources of and facilitating access by patients and their families to financial support from copay support, patient assistance programs (PAP), patient foundations and organizations; financial services, namely, administration of patient reimbursement programs
- Class 041 — Education and entertainment services: Educational services, namely, providing online newsletters in the field of prescription drug information via emails, non-downloadable webinars, and online non-downloadable videos in the field of prescription drug information; educational services, namely, providing prescription drug dosage training; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; providing information regarding tumors and cancer, and pediatric low-grade glioma
- Class 042 — Scientific and technological services: Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological, neurological, and immune system diseases and disorders; research, development, and medical evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of oncological, neurological, and immune system related diseases and disorders
Owner
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
Prior registrations
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jan 2026 — USE AMENDMENT FILED
- 13 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 May 2025 — PUBLISHED FOR OPPOSITION
- 14 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Apr 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED